Beware the Parabolic Curve in Biotech

By Dave Skarica  FEB 20, 2014 10:04 AM

Biotech stocks outperformed the market during the 2008 financial crisis. In late 2011, something changed: Loose money piled in.

 


No positions in stocks mentioned.